Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic and infectious diseases
3.2.1.2 Advancements in blood collection technologies
3.2.1.3 Increasing number of surgical procedures
3.2.1.4 Rising geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of blood collection equipment
3.2.2.2 Risks associated with blood transfusions
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.6.1 By region
3.6.2 By key player
3.7 Future market trends
3.8 Pipeline analysis
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Venous
5.2.1 Needles and syringes
5.2.1.1 Double-ended needles
5.2.1.2 Winged blood collection sets
5.2.1.3 Standard hypodermic needles
5.2.1.4 Other blood collection needles
5.2.2 Blood collection tubes
5.2.2.1 Serum-separating
5.2.2.2 EDTA
5.2.2.3 Heparin
5.2.2.4 Plasma-separating
5.2.3 Blood bags
5.2.4 Other venous products
5.3 Capillary
5.3.1 Lancets
5.3.2 Micro-container tubes
5.3.3 Micro-hematocrit tubes
5.3.4 Warming devices
5.3.5 Other capillary products
Chapter 6 Market Estimates and Forecast, By Method, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Manual blood collection
6.3 Automated blood collection
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Diagnostics
7.3 Treatment
7.4 Research
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals and clinics
8.3 Diagnostic centers
8.4 Blood banks
8.5 Academic and research institutes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Becton, Dickinson and Company
10.3 Cardinal Health, Inc.
10.4 F. Hoffmann-La Roche Ltd.
10.5 FL MEDICAL s.r.l.
10.6 Fresenius SE & Co. KGaA
10.7 Haemonetics Corporation
10.8 Greiner AG
10.9 McKESSON CORPORATION
10.10 Medtronic plc
10.11 Nipro Corporation
10.12 QIAGEN N.V.
10.13 Sarstedt AG & Co. KG
10.14 Siemens Healthineers AG
10.15 Terumo Corporation
10.16 Thermo Fisher Scientific Inc.
